𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MONITORING INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER USING FLUORESCENCE IN SITU HYBRIDIZATION

✍ Scribed by KIPP, B; KARNES, R; BRANKLEY, S; HARWOOD, A; PANKRATZ, V; SEBO, T; BLUTE, M; LIEBER, M; ZINCKE, H; HALLING, K

Book ID
122505733
Publisher
Lippincott Williams and Wilkins
Year
2005
Tongue
English
Weight
81 KB
Volume
173
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Urinary interleukins in patients receivi
Urinary interleukins in patients receiving intravesical bacillus calmette-guerin therapy for superficial bladder cancer
✍ Jonathan D. Fleischmann; Zahra Toossi; Jerrold J. Ellner; Deborah B. Wentworth; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 668 KB

## Intravesical administration of Bacillus Calmette-Guerin (BCG) causes a localized cell-mediated immune response. The intensity of this inflammatory response may be gauged by measuring the levels of both interleukin-2 (IL-2) and an inhibitor of interleukin-2 (IL-2-IN) activity in the urine during